Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.1% while the Hang Seng is down 0.2%. The Shanghai Composite is trading down by 0.4%.
Back home, India share markets opened the day on a flat note. The BSE Sensex is trading higher by 15 points while the NSE Nifty is trading up by 3 points. The BSE Mid Cap index and BSE Small Cap index both opened the day up by 0.4 & 0.2% respectively.
Sectoral indices have opened the day on a mixed note with metal stocks and stocks in the power sector witnessing buying interest. While, IT stocks & energy stocks have opened the day in red. The rupee is trading at 65.46 to the US$.
In news from stocks in the pharma sector. Cipla share price is in focus today after the United States Food & Drug Administration (USFDA) completed its inspection of the company's Indore facility with no integrity or repeat observations for the unit.
The US regulator which began inspections on 2 April 2018, cleared the facility with nothing adverse to report.
--- Advertisement --- How We Were Able To Predict The Rise Of The IT Sector... The NSE IT Index has moved up more than 21% between 16th August 2017 and 31st January 2018. Would you believe me if we told you one of our senior research analysts, Apurva Sheth, had predicted this rise in advance? Yes! Not only that, Apurva also zeroed in on one IT stock he believed would benefit greatly from the rise. And that's exactly what happened. So what strategy did Apurva use for it? And how could YOU potentially benefit from it now too? Click here for full details… ------------------------------ |
Note that Cipla's Indore facility had earlier received nine observations from the USFDA in 2015 and which were cleared in 2016.
Further, in January 2018, the USFDA had conducted a product specific pre-approval inspection at Goa plant and issued certain observations which were procedural in nature. Post that inspection, it had received two product approvals from the plant.
Cipla share price opened the day down by 0.3%.
Speaking of pharma stocks, Divis Laboratories share price has hit a 52-week high. Things seem to be looking up for the pharma sector.
Is this the right time to buy pharma stocks?
There was a time when almost every stock in the pharma sector was considered to be a safe stock. You could just pick the top 5-6 companies from this sector and expect to make decent returns over time.
In fact, it was termed as defensive sector. However, in last two years things have changed a lot. There is enormous uncertainty in the industry.
Uncertainty regarding price erosion in the United States as well as hostile US FDA visits, have changed a once defensive sector into a risky sector.
However, we believe this could be point of consolidation in the industry i.e. with stricter norms, lower margins, and pricing pressure, the industry may see many exits and acquisitions. This could lead to relatively fewer but higher quality players.
We believe, if you can pick a niche company with good financials and strong management, this is a good time to consider pharma stocks.
Moving on to news that could bring cheer to the economy, the Indian Meteorological Department (IMD) predicted 'normal' monsoon rains this year.
In its first stage long range forecast the IMD said that rainfall will be 97% of the 50-year average with a 54% probability that rains will be normal to above normal.
Probability that rainfall will be deficient (less than 90% of 50 year average) is 14%, it added.
A normal, or average, monsoon means rainfall between 96% and 104% of a 50-year average of 89 cm (35 inches) in total during the four-month monsoon season from June, according to the IMD's classification.
The onset of the monsoon in June is the trigger for planting of rain-fed Kharif crops. India receives 70% of its annual rainfall in the four-month period, which in turn irrigates over half of its farm lands lacking assured irrigation.
A normal monsoon is crucial to push economic growth, which slowed last year under the lingering impact of demonetisation and disruptions due to implementation of the goods and services tax (GST), both of which impacted private consumption demand as well as exports.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
What else is happening in the markets today? Dig in...
MRPL share price has hit a 52-week high. It is presently trading at Rs 45. BSE 500 Index is up by 1.7% at 19,713. Within the BSE 500, MRPL (up 8.3%) and RCF (up 20.0%) are among the top gainers, while top losers are HIMADRI SPECIALITY CHEMICAL and BHARTI AIRTEL.
KEC INTERNATIONAL share price is trading up by 5% and its current market price is Rs 454. The BSE CAPITAL GOODS is up by 1.6%. The top gainers in the BSE CAPITAL GOODS Index are KEC INTERNATIONAL (up 5.2%) and BHARAT ELECTRONICS (up 6.5%). The top losers are SCHAEFFLER INDIA (down 0.2%) and HINDUSTAN AERO. (down 0.3%).
GUJARAT ALKALIES share price is trading up by 10% and its current market price is Rs 346. The BSE 500 is up by 1.6%. The top gainers in the BSE 500 Index are GUJARAT ALKALIES (up 10.2%) and DEEPAK NITRITE (up 14.5%). The top losers are COLGATE and HDFC AMC .
DEEPAK NITRITE share price is trading up by 13% and its current market price is Rs 1,553. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are DEEPAK NITRITE (up 12.8%) and JUST DIAL (up 14.2%). The top losers are BAJAJ HOLDINGS & INVESTMENT and CADILA HEALTHCARE .
HIMADRI SPECIALITY CHEMICAL share price is trading down by 11% and its current market price is Rs 55. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are RCF (up 20.0%) and MMTC (up 20.0%). The top losers is HIMADRI SPECIALITY CHEMICAL (down 11.3%).
BSE Sensex is trading up by 378 points, while the NSE Nifty is trading up by 165 points.
View More Indian Share Market NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
In this video, I'll show you how to get started on the path to daily trading profits.
More
Equitymaster requests your view! Post a comment on "Sensex Opens Flat; IMD Predicts Normal Monsoon for 2018". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!